Cargando…
Eltrombopag Use for Treatment of Thrombocytopenia in a Patient with Chronic Liver Disease and Portal Vein Thrombosis: Case Report
Off-label drug use refers to drug use beyond the specifications authorized for marketing [J Med Case Rep. 2014 Dec;8(1):303]. Eltrombopag is a thrombopoietin receptor agonist that has been used in treating thrombocytopenia due to chronic liver disease (CLD) as an off-label medication. Treatment of t...
Autores principales: | Mohamed, Sabah E., Yassin, Mohamed A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443640/ https://www.ncbi.nlm.nih.gov/pubmed/32884532 http://dx.doi.org/10.1159/000507987 |
Ejemplares similares
-
Severe Portal Vein Thrombosis During Eltrombopag Treatment Concomitant Splenectomy for Immune Thrombocytopenia
por: Saito, Makoto, et al.
Publicado: (2021) -
Helicobacter pylori infection manifesting as Hypereosinophilic syndrome and immune thrombocytopenia complicated by portal vein thrombosis and ischemic colitis
por: Alshurafa, Awni, et al.
Publicado: (2022) -
Eltrombopag-related renal vein thromboembolism in a patient with immune thrombocytopenia: A case report
por: Wu, Cen, et al.
Publicado: (2021) -
Rupture of a liver hydatid cyst into the right portal vein leading to right portal vein thrombosis: a case report and literature review
por: Ammar, Houssem, et al.
Publicado: (2023) -
Risk of Thromboembolism With Eltrombopag: A Case Report of Deep Vein Thrombosis and Bilateral Pulmonary Embolism
por: Ghumman, Ghulam Mujtaba, et al.
Publicado: (2023)